A non-interventional study on the tolerability of octagam(R) 5% and octagam(R) 10%

Trial Profile

A non-interventional study on the tolerability of octagam(R) 5% and octagam(R) 10%

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Dec 2016

At a glance

  • Drugs Immune globulin (Primary)
  • Indications Graft-versus-host disease; Immunodeficiency disorders
  • Focus Adverse reactions
  • Acronyms GammaTrack
  • Sponsors Octapharma
  • Most Recent Events

    • 01 Nov 2016 Results assessing safety and tolerability using data from this and other three trials published in the International Journal of Clinical Pharmacology and Therapeutics.
    • 10 Oct 2016 Results assessing safety and tolerability using data from this and other three trials published in the International Journal of Clinical Pharmacology and Therapeutics
    • 19 Apr 2013 New source identified and integrated (United Kingdom Clinical Research Network record, 13403).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top